OVERSEA CHINESE BANKING Corp Ltd Acquires New Shares in Agilent Technologies, Inc. $A

OVERSEA CHINESE BANKING Corp Ltd acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 26,530 shares of the medical research company’s stock, valued at approximately $3,524,000.

Several other large investors have also added to or reduced their stakes in A. Norges Bank purchased a new position in Agilent Technologies during the 4th quarter valued at about $549,158,000. Bank of New York Mellon Corp lifted its holdings in shares of Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after buying an additional 2,440,360 shares in the last quarter. AQR Capital Management LLC lifted its holdings in shares of Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after buying an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. boosted its position in shares of Agilent Technologies by 132.2% in the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after acquiring an additional 1,340,161 shares during the period. Finally, Deutsche Bank AG boosted its position in shares of Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after acquiring an additional 1,024,516 shares during the period.

Analyst Ratings Changes

A has been the subject of several recent analyst reports. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Barclays increased their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 24th. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Morgan Stanley boosted their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Finally, TD Cowen upped their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies Stock Up 0.7%

A stock opened at $156.50 on Friday. The company’s 50 day moving average is $136.98 and its 200 day moving average is $126.00. The stock has a market cap of $44.20 billion, a price-to-earnings ratio of 31.43, a price-to-earnings-growth ratio of 2.75 and a beta of 1.25. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the business posted $1.31 earnings per share. Agilent Technologies’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.